Zobrazeno 1 - 3
of 3
pro vyhledávání: '"P G, Maslak"'
Autor:
Peter G. Maslak, Tao Dao, Yvette Bernal, Suzanne M. Chanel, Rong Zhang, Mark Frattini, Todd Rosenblat, Joseph G. Jurcic, Renier J. Brentjens, Maria E. Arcila, Raajit Rampal, Jae H. Park, Dan Douer, Laura Katz, Nicholas Sarlis, Martin S. Tallman, David A. Scheinberg
Publikováno v:
Blood Advances, Vol 2, Iss 3, Pp 224-234 (2018)
Abstract: A National Cancer Institute consensus study on prioritization of cancer antigens ranked the Wilms tumor 1 (WT1) protein as the top immunotherapy target in cancer. We previously reported a pilot study of a multivalent WT1 peptide vaccine (ga
Externí odkaz:
https://doaj.org/article/e8c8ca07418543a4ba9a1d688ecc3f94
Publikováno v:
Current topics in microbiology and immunology. 313
Acute promyelocytic leukemia (APL) is a rare subtype of acute myeloid leukemia (AML) for which a number of targeted therapies have been developed. The "targets" have included both genotypic and phenotypic features of the disease. The application of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::65ad867f4e9ef6894eb12b738af86153
https://pubmed.ncbi.nlm.nih.gov/17217045
https://pubmed.ncbi.nlm.nih.gov/17217045
Publikováno v:
Leukemia. 10(1)
Given the high treatment-related mortality in elderly patients with acute myelogenous leukemia (AML), we undertook a study using granulocyte colony-stimulating factor (G-CSF) following chemotherapy in an effort to ameliorate toxicity. Patients (60 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c95ddecacb9682d6b87cb2dc1fd02b4a
https://pubmed.ncbi.nlm.nih.gov/8558934
https://pubmed.ncbi.nlm.nih.gov/8558934